semaglutide eye blindness A new study suggests patients taking — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an condition that can cause blindness. Non-arteritic anterior Update on Semaglutide Risks -

Comments should be no longer than 500 words and will only be posted online

Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro, and for chronic weight management as Zepbound

CJC 1295 without DAC mimics natural GH release, producing short bursts just like the body does on its own

Of note, exendin-4 was serendipitously discovered in the saliva of the Gila monster ( Heloderma suspectum ) and was revealed to be a GLP-1 analog that is resistant to DPP-4 action in 1992, even before the mechanism of GLP-1 degradation was identified [7]

What we do not yet know Critical gaps remain in the evidence base